Ophthalmology Reimbursed

From ASCRS 2026: New Frontiers in Eye Care (Part 3) – Featuring Alcon

In Part 3 of our ASCRS 2026 series, we explore photobiomodulation and its potential role in advancing eye care. We’re joined by Traci Brackett and Joshua Anderson from Alcon, who share their insights on this emerging therapy, how it works, and where it may fit into clinical practice. From innovation to real-world application, this conversation highlights what providers should know as new technologies continue to shape the future of patient care. Contact us by calling (800) 399-6565 or visiting CorcoranCCG. [https://corcoranccg.com/]

From ASCRS 2026: iDose TR & Interventional Glaucoma (IG) (Part 2) – Featuring Glaukos

In Part 2 of our ASCRS 2026 coverage, we dive into iDose TR and the evolution of interventional glaucoma. Joined by Tom Powell and Cynthia Pointer from Glaukos, we explore what these innovations mean in practice, how they’re changing treatment approaches, and what providers should be paying attention to moving forward. Contact us by calling (800) 399-6565 or visiting CorcoranCCG. [https://corcoranccg.com/]

From ASCRS 2026: Key Conversations & Insights (Part 1) – Promptly’s Anish Kapur

This is Part 1 of our ASCRS series.  In this episode, we are sharing key highlights and emerging trends discussed at the recent ASCRS/ASOA meeting in Washington, DC. We’re joined by Anish Kapur, who offers his perspective on what’s shaping the industry—grounded in his work with Promptly, a patient engagement platform focused on streamlining payments, collections, and patient communication through automation and AI. Contact us by calling (800) 399-6565 or visiting CorcoranCCG. [https://corcoranccg.com/]

Botulinum Toxin Billing Updates: New Coverage Rules You Can’t Ignore

As a follow up to our last podcast addressing correct billing for injectable medications, this episode focuses specifically on recent changes to coverage polices for Botulinum toxin injections. Recent instructions on coverage, frequency, sharing vials and documentation will require practices to rethink their process and pay closer attention to charting. Contact us by calling (800) 399-6565 or visiting CorcoranCCG. [https://corcoranccg.com/]

J-Codes & Drug Billing Risk: What Ophthalmic Practices Need to Understand

Drug billing continues to be a high-risk area for ophthalmology practices. In this episode, Mary Pat Johnson and Rebecca Greenlaw discuss key considerations related to ophthalmology J-codes, including modifier use, dosing accuracy, Medicare reimbursement, and how drug billing decisions can affect performance under MIPS. This practical conversation is designed to help practices reduce audit risk and strengthen compliance. Contact us by calling (800) 399-6565 or visiting CorcoranCCG. [https://corcoranccg.com/]